NCCN has expanded the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Survivorship to include a section on cancer-associated cognitive impairment and to include chemotherapy-induced peripheral neuropathy as a component of the section on adult cancer pain.
The inaugural guidelines for cognitive impairment were presented at the NCCN 19th Annual Conference by Elizabeth Kvale, MD, Director of Supportive Care and Survivorship, University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, and Susan G. Urba, MD, Professor, Medical Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, described the new section on peripheral neuropathy.
Jim HS, Phillips KM, Chait S et al.. Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. J Clin Oncol 2012;30:3578–3587.
Smith EM, Pang H, Cirrincione C et al.. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA 2013;309:1359.